Comparison Overview

Rapid Deployment Sales (RDS)

VS

Future Science Group

Rapid Deployment Sales (RDS)

165 Ashley Mews Dr, Ann Arbor, Michigan, 48104, US
Last Update: 2025-11-26
View Profile
Between 750 and 799
https://rapiddeploymentsales.com

We offer on demand selling services on a project basis. It’s a flexible, low risk way to help you drive sales. From sales deployment to go to market planning. We’re focused in education markets from K-12 to Higher Education and the Library Market. RDS has a team of sales professionals available as a turn-key solution to help you launch products, drive sales campaigns or conduct Market Research. We can quickly identify the right sales team to help you accomplish your business objectives. By utilizing our experienced sales professionals, we take the staffing and management of the sales team off your hands to allow you to dedicate more time to focus on your day to day priorities. Our sales teams specialize in driving sales from transactional to consultative. RDS will help you chart your path to success using our experienced educational sales team that will close sales for you as you launch new products or supplement existing sales efforts.

NAICS: 511
NAICS Definition:
Employees: 2
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Future Science Group

Unitec House, London, undefined, N3 1QB, GB
Last Update: 2025-11-26
Between 750 and 799
http://www.future-science-group.com

VISION IN SCIENTIFIC AND MEDICAL PUBLISHING Founded in 2001, Future Science Group is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. Future Science Group’s portfolio consists of two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, Future Science Group develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Pharmacogenomics and the award-winning Regenerative Medicine. The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. Learn more about Future Science Group at www.future-science-group.com

NAICS: 511
NAICS Definition:
Employees: 45
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/rapid-deployment-sales.jpeg
Rapid Deployment Sales (RDS)
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/future-science-group.jpeg
Future Science Group
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Rapid Deployment Sales (RDS)
100%
Compliance Rate
0/4 Standards Verified
Future Science Group
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Rapid Deployment Sales (RDS) in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Future Science Group in 2025.

Incident History — Rapid Deployment Sales (RDS) (X = Date, Y = Severity)

Rapid Deployment Sales (RDS) cyber incidents detection timeline including parent company and subsidiaries

Incident History — Future Science Group (X = Date, Y = Severity)

Future Science Group cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/rapid-deployment-sales.jpeg
Rapid Deployment Sales (RDS)
Incidents

No Incident

https://images.rankiteo.com/companyimages/future-science-group.jpeg
Future Science Group
Incidents

No Incident

FAQ

Rapid Deployment Sales (RDS) company demonstrates a stronger AI Cybersecurity Score compared to Future Science Group company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Future Science Group company has disclosed a higher number of cyber incidents compared to Rapid Deployment Sales (RDS) company.

In the current year, Future Science Group company and Rapid Deployment Sales (RDS) company have not reported any cyber incidents.

Neither Future Science Group company nor Rapid Deployment Sales (RDS) company has reported experiencing a ransomware attack publicly.

Neither Future Science Group company nor Rapid Deployment Sales (RDS) company has reported experiencing a data breach publicly.

Neither Future Science Group company nor Rapid Deployment Sales (RDS) company has reported experiencing targeted cyberattacks publicly.

Neither Rapid Deployment Sales (RDS) company nor Future Science Group company has reported experiencing or disclosing vulnerabilities publicly.

Neither Rapid Deployment Sales (RDS) nor Future Science Group holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Rapid Deployment Sales (RDS) company nor Future Science Group company has publicly disclosed detailed information about the number of their subsidiaries.

Future Science Group company employs more people globally than Rapid Deployment Sales (RDS) company, reflecting its scale as a Book and Periodical Publishing.

Neither Rapid Deployment Sales (RDS) nor Future Science Group holds SOC 2 Type 1 certification.

Neither Rapid Deployment Sales (RDS) nor Future Science Group holds SOC 2 Type 2 certification.

Neither Rapid Deployment Sales (RDS) nor Future Science Group holds ISO 27001 certification.

Neither Rapid Deployment Sales (RDS) nor Future Science Group holds PCI DSS certification.

Neither Rapid Deployment Sales (RDS) nor Future Science Group holds HIPAA certification.

Neither Rapid Deployment Sales (RDS) nor Future Science Group holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
References
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References
Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References